These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 39076382)
1. The Association between Serum Creatinine/Cystatin C Ratio and Cardiovascular Morbidity and Mortality: Insights from NHANES. Shi J; Wu Y; Zhu S; Xie Y; Xiang M Rev Cardiovasc Med; 2023 Sep; 24(9):275. PubMed ID: 39076382 [TBL] [Abstract][Full Text] [Related]
2. The relationship between serum creatinine/cystatin C ratio and mortality in hypertensive patients. Liao L; Shi S; Ding B; Zhang R; Tu J; Zhao Y; Guo Q; Liao Y Nutr Metab Cardiovasc Dis; 2024 Feb; 34(2):369-376. PubMed ID: 37949717 [TBL] [Abstract][Full Text] [Related]
3. Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease. Hyun YY; Lee KB; Kim H; Kim Y; Chung W; Park HC; Han SH; Oh YK; Park SK; Oh KH Front Nutr; 2022; 9():996674. PubMed ID: 36225865 [TBL] [Abstract][Full Text] [Related]
4. Cystatin C Is a Predictor for Long-Term, All-Cause, and Cardiovascular Mortality in US Adults With Metabolic Syndrome. Song X; Xiong L; Guo T; Chen X; Zhang P; Zhang X; Liang Z J Clin Endocrinol Metab; 2024 Oct; 109(11):2905-2919. PubMed ID: 38597157 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of the Creatinine/Cystatin C ratio for low muscle mass evaluation among US adults. Shi S; Jiang Y; Chen W; Chen K; Liao Y; Huang K Front Nutr; 2022; 9():897774. PubMed ID: 36017221 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of the serum creatinine/cystatin C ratio in patients with chronic obstructive pulmonary disease. Kawasaki Y; Nishiki K; Nojiri M; Kato R; Shinomiya S; Oikawa T; Ishizaki T; Toga H; Mizuno S Respir Investig; 2024 Jan; 62(1):143-149. PubMed ID: 38134662 [TBL] [Abstract][Full Text] [Related]
7. Clinical muscle mass-related biomarkers that predict mortality in older patients with community-acquired pneumonia. Huang S; Guo Y; Chen L; Wang Y; Chen X BMC Geriatr; 2022 Nov; 22(1):880. PubMed ID: 36402966 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of serum creatinine and cystatin C ratio as a screening tool for predicting prognosis in patients with pancreatic cancer. Tsukagoshi M; Watanabe A; Araki K; Ishii N; Hagiwara K; Hoshino K; Muranushi R; Harimoto N; Takizawa M; Shirabe K Ann Gastroenterol Surg; 2023 Sep; 7(5):784-792. PubMed ID: 37663967 [TBL] [Abstract][Full Text] [Related]
9. Associations of serum cystatin C concentrations with total mortality and mortality of 12 site-specific cancers. Huang C; Lu J; Yang J; Wang Z; Hang D; Fu Z Front Mol Biosci; 2024; 11():1209349. PubMed ID: 38725873 [TBL] [Abstract][Full Text] [Related]
10. Decreased serum creatinine to cystatin C ratio is associated with low tongue pressure. Komorita Y; Ide H; Yoshinari M; Ohta Y; Nakamichi I; Fujisawa R; Fujii W; Fukuhara M Geriatr Gerontol Int; 2024 Jan; 24(1):102-108. PubMed ID: 38110724 [TBL] [Abstract][Full Text] [Related]
11. Joint Associations of Pregnancy Complications and Postpartum Maternal Renal Biomarkers With Severe Cardiovascular Morbidities: A US Racially and Ethnically Diverse Prospective Birth Cohort Study. Hong X; Rosenberg AZ; Heymann J; Yoshida T; Waikar SS; Ilori TO; Wang G; Rebuck H; Pearson C; Wang MC; Winkler CA; Kopp JB; Wang X J Am Heart Assoc; 2023 Nov; 12(22):e029311. PubMed ID: 37947096 [TBL] [Abstract][Full Text] [Related]
12. Impact of the serum creatinine and cystatin C ratio for prediction of sarcopenia and prognosis in biliary tract cancer. Fukushima R; Harimoto N; Okuyama T; Seki T; Hoshino K; Hagiwara K; Kawai S; Ishii N; Tsukagoshi M; Igarashi T; Araki K; Shirabe K Int J Clin Oncol; 2024 Jul; 29(7):1002-1011. PubMed ID: 38683456 [TBL] [Abstract][Full Text] [Related]
13. Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours. Ding P; Guo H; Sun C; Chen S; Yang P; Tian Y; Lowe S; Zhao Q Front Nutr; 2022; 9():963265. PubMed ID: 36118766 [TBL] [Abstract][Full Text] [Related]
14. Serum creatinine/cystatin C ratio is a predictor of all-cause mortality for older adults over 80 years. Zhang L; Jin J; Tu YY; Zhao Z; Tao J; Zhang XY Heliyon; 2023 Mar; 9(3):e14214. PubMed ID: 36994407 [TBL] [Abstract][Full Text] [Related]
15. Serum Creatinine to Cystatin C Ratio is an Effective Indicator for Muscle Strength Decline in Men with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Huang D; Xie C; Sun C; Chen M; Li L; Yi H; Liao J; Zhao X; Shen X; He D; Li D; Wu D Int J Chron Obstruct Pulmon Dis; 2022; 17():781-789. PubMed ID: 35422619 [TBL] [Abstract][Full Text] [Related]
16. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR in Heart Failure With Reduced Ejection Fraction: Insights From PARADIGM-HF. Pinsino A; Carey MR; Husain S; Mohan S; Radhakrishnan J; Jennings DL; Nguonly AS; Ladanyi A; Braghieri L; Takeda K; Faillace RT; Sayer GT; Uriel N; Colombo PC; Yuzefpolskaya M Am J Kidney Dis; 2023 Nov; 82(5):521-533. PubMed ID: 37086965 [TBL] [Abstract][Full Text] [Related]
17. The cystatin C/creatinine ratio, a marker of glomerular filtration quality: associated factors, reference intervals, and prediction of morbidity and mortality in healthy seniors. Purde MT; Nock S; Risch L; Medina Escobar P; Grebhardt C; Nydegger UE; Stanga Z; Risch M Transl Res; 2016 Mar; 169():80-90.e1-2. PubMed ID: 26637934 [TBL] [Abstract][Full Text] [Related]
18. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease. Hirai K; Tanaka A; Homma T; Goto Y; Akimoto K; Uno T; Yoshitaka U; Miyata Y; Inoue H; Ohta S; Suzuki S; Sagara H Clin Nutr; 2021 Mar; 40(3):1274-1280. PubMed ID: 32863062 [TBL] [Abstract][Full Text] [Related]
19. Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis. Fujita K; Ohkubo H; Nakano A; Takeda N; Fukumitsu K; Fukuda S; Kanemitsu Y; Uemura T; Tajiri T; Maeno K; Ito Y; Oguri T; Ozawa Y; Murase T; Niimi A BMC Pulm Med; 2022 May; 22(1):203. PubMed ID: 35606777 [TBL] [Abstract][Full Text] [Related]
20. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer. Sun J; Yang H; Cai W; Zheng J; Shen N; Yang X; Pan B; Zhang W; Chen X; Shen X BMC Gastroenterol; 2022 Jan; 22(1):26. PubMed ID: 35045814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]